Soleno Therapeutics to Present at the Piper Sandler 37th Annual Healthcare Conference

Core Insights - Soleno Therapeutics, Inc. is participating in the Piper Sandler 37 Healthcare Conference on December 4, 2025, with CEO Anish Bhatnagar scheduled for a fireside chat [1] Company Overview - Soleno Therapeutics focuses on developing and commercializing novel therapeutics for rare diseases [3] - The company's first commercial product is VYKAT™ XR (diazoxide choline) extended-release tablets, designed for treating hyperphagia in individuals with Prader-Willi syndrome aged 4 years and older [3]